Are estrogen receptors alpha detectable in normal and abnormal thyroid tissue?
- PMID: 20473764
- DOI: 10.1007/s00405-010-1269-0
Are estrogen receptors alpha detectable in normal and abnormal thyroid tissue?
Abstract
The aims of this study is to evaluate the presence of estrogen receptors alpha (ERα) in thyroid lesions and to assess the practicality of this test in view of numerous disagreements on the subject. Immunohistochemical stains were performed for ERα, for the evaluation of immunoreactivity in 296 pathological thyroid tissue samples. We evaluated the intensity of the nuclear and cytoplasmatic staining and the spread of the stain over the sample. Thirty cases of the breast cancer served as a control group. None of the histological thyroid samples showed immunoreactivity for ERα. No difference was found between the various lesions in regard to this absence. The ERα rate of expression in the breast cancer samples was 60%. The ERα is undetectable in the histological samples of benign and malignant thyroid lesions. Further investigation is necessary in the laboratory immunohistochemical workup in order to exclude a possibility of non-specific staining.
Similar articles
-
The estrogen receptors in the papillary carcinoma of the thyroid gland.Oncol Res. 2010;18(11-12):537-40. doi: 10.3727/096504010x12767359113802. Oncol Res. 2010. PMID: 20939429
-
Diagnostic value of estrogen receptors in thyroid lesions.Med Sci Monit. 2010 Jul;16(7):BR203-7. Med Sci Monit. 2010. PMID: 20581768
-
Estrogen receptors (alpha and beta) and 17beta-hydroxysteroid dehydrogenase type 1 and 2 in thyroid disorders: possible in situ estrogen synthesis and actions.Mod Pathol. 2003 May;16(5):437-44. doi: 10.1097/01.MP.0000066800.44492.1B. Mod Pathol. 2003. PMID: 12748250
-
beta-Catenin expression in thyroid follicular lesions: potential role in nuclear envelope changes in papillary carcinomas.Endocr Pathol. 2004 Winter;15(4):329-37. doi: 10.1385/ep:15:4:329. Endocr Pathol. 2004. PMID: 15681857 Review.
-
Estrogen activity as a preventive and therapeutic target in thyroid cancer.Biomed Pharmacother. 2012 Mar;66(2):151-8. doi: 10.1016/j.biopha.2011.11.010. Epub 2011 Dec 28. Biomed Pharmacother. 2012. PMID: 22285105 Review.
Cited by
-
Expression of estrogen and progesterone receptors in papillary thyroid carcinoma.Caspian J Intern Med. 2016 Summer;7(3):183-187. Caspian J Intern Med. 2016. PMID: 27757203 Free PMC article.
-
Estrogens and stem cells in thyroid cancer.Front Endocrinol (Lausanne). 2014 Jul 25;5:124. doi: 10.3389/fendo.2014.00124. eCollection 2014. Front Endocrinol (Lausanne). 2014. PMID: 25120531 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical